编号:1
题目:A single-dose, open-label, parallel, randomized,dose-proportionality study of paliperidone after intramuscular injections ofpaliperidone palmitate in the deltoid or gluteal muscle in patients withschizophrenia.
作者:Cleton A1, Rossenu S, Crauwels H, Berwaerts J, Hough D, Gopal S,Eerdekens M, Vandebosch A, Remmerie B, De Meulder M, Fernández CM
杂志:J Clin Pharmacol.
页码:2014 Sep;54(9):1048-57. doi: 10.1002/jcph.295. Epub 2014 Apr 3
链接:http://onlinelibrary.wiley.com/doi/10.1002/jcph.295/abstract
编号:2
题目:Pharmacokinetics and tolerability of paliperidone palmitateinjection in Chinese subjects
作者:Si T1, Su Y, Liu Y, Zhang H, Li H, Rui Q, Shu L.
杂志:Hum Psychopharmacol.
页码:2014 Mar;29(2):203-10. doi: 10.1002/hup.2388
链接:http://onlinelibrary.wiley.com/doi/10.1002/hup.2388/abstract
编号:3
题目:The pharmacokinetics of long-acting antipsychotic medications.
作者:Spanarello S, La Ferla T1.
杂志:Curr Clin Pharmacol.
页码:2014;9(3):310-7.
链接:http://www.ncbi.nlm.nih.gov/pubmed/23343447